These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 1384340
1. Enhanced tenascin expression in cervical and vulvar koilocytotic lesions. Tiitta O, Wahlström T, Paavonen J, Linnala A, Sharma S, Gould VE, Virtanen I. Am J Pathol; 1992 Oct; 141(4):907-13. PubMed ID: 1384340 [Abstract] [Full Text] [Related]
2. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Howeedy AA, Virtanen I, Laitinen L, Gould NS, Koukoulis GK, Gould VE. Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508 [Abstract] [Full Text] [Related]
3. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast. Koukoulis GK, Howeedy AA, Korhonen M, Virtanen I, Gould VE. J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813 [Abstract] [Full Text] [Related]
4. Differential distribution of tenascin and cellular fibronectins in acute and chronic renal allograft rejection. Gould VE, Martinez-Lacabe V, Virtanen I, Sahlin KM, Schwartz MM. Lab Invest; 1992 Jul; 67(1):71-9. PubMed ID: 1378105 [Abstract] [Full Text] [Related]
5. Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters. Pilch H, Schäffer U, Schlenger K, Lautz A, Tanner B, Höckel M, Knapstein PG. Gynecol Oncol; 1999 Jun; 73(3):415-21. PubMed ID: 10366470 [Abstract] [Full Text] [Related]
6. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions. Tervahauta AI, Syrjänen SM, Väyrynen M, Saastamoinen J, Syrjänen KJ. Anticancer Res; 1993 Jun; 13(4):1107-11. PubMed ID: 8394670 [Abstract] [Full Text] [Related]
7. Tenascin expression in the human endometrium and in endometrial adenocarcinomas. Vollmer G, Siegal GP, Chiquet-Ehrismann R, Lightner VA, Arnholdt H, Knuppen R. Lab Invest; 1990 Jun; 62(6):725-30. PubMed ID: 1694256 [Abstract] [Full Text] [Related]
8. Detection of human papillomavirus in cervical smears. A comparison of in situ hybridization, immunocytochemistry and cytopathology. Gupta JW, Gupta PK, Rosenshein N, Shah KV. Acta Cytol; 1987 Jun; 31(4):387-96. PubMed ID: 3037829 [Abstract] [Full Text] [Related]
9. Tenascin in preinvasive lesions of the vulva and vulvar cancer. Goepel C, Stoerer S, Koelbl H. Anticancer Res; 2003 Jun; 23(6C):4587-91. PubMed ID: 14981900 [Abstract] [Full Text] [Related]
10. Tenascin expression in normal and abnormal human endometrium. Sasano H, Nagura H, Watanabe K, Ito K, Tsuiki A, Sato S, Yajima A, Kusakabe M, Sakakura T. Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462 [Abstract] [Full Text] [Related]
11. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A, Vang R, Seidman JD, Gravitt PE, Ronnett BM. Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [Abstract] [Full Text] [Related]
12. [Detection of HPV-DNA in the various uterocervical lesions by in situ hybridization]. Ishi K, Kina K, Kawashima T, Shimota H, Utsuno H, Takada M. Rinsho Byori; 1989 Nov; 37(11):1284-8. PubMed ID: 2557468 [Abstract] [Full Text] [Related]
13. Occurrence of multiple types of human papillomavirus in genital tract lesions. Analysis by in situ hybridization and the polymerase chain reaction. Nuovo GJ, Darfler MM, Impraim CC, Bromley SE. Am J Pathol; 1991 Jan; 138(1):53-8. PubMed ID: 1846265 [Abstract] [Full Text] [Related]
14. Human papillomavirus (HPV) infection of cervical lesions detected by immunohistochemistry and in situ hybridization. Hoepfner I, Löning T. Cancer Detect Prev; 1986 Jan; 9(3-4):293-301. PubMed ID: 3017555 [Abstract] [Full Text] [Related]
15. Cytologic and histologic manifestations of human papillomavirus infection of the uterine cervix. Koss LG. Cancer Detect Prev; 1990 Jan; 14(4):461-4. PubMed ID: 2171769 [Abstract] [Full Text] [Related]
17. Morphometric assessment of the biological potential of human papillomavirus infections in the uterine cervix. Tosi P, Luzi P, Santopietro R, Miracco C, Lio R, Syrjänen S, Mäntyjärvi R, Syrjänen K. Appl Pathol; 1988 Nov; 6(4):247-57. PubMed ID: 2846018 [Abstract] [Full Text] [Related]
18. Detection of human papillomavirus DNA sequences in cervical lesions by in situ hybridization using biotinylated DNA probes. Zhang ZS, Wu YL, Xu LL, Yang YH. Chin Med J (Engl); 1992 Apr; 105(4):293-7. PubMed ID: 1319885 [Abstract] [Full Text] [Related]
19. Detection of human papillomavirus in normal and dysplastic tissue by the polymerase chain reaction. Shibata D, Fu YS, Gupta JW, Shah KV, Arnheim N, Martin WJ. Lab Invest; 1988 Oct; 59(4):555-9. PubMed ID: 2845193 [Abstract] [Full Text] [Related]
20. Aberrant expression of alpha-dystroglycan in cervical and vulvar cancer. Sgambato A, Tarquini E, Resci F, De Paola B, Faraglia B, Camerini A, Rettino A, Migaldi M, Cittadini A, Zannoni GF. Gynecol Oncol; 2006 Nov; 103(2):397-404. PubMed ID: 16765426 [Abstract] [Full Text] [Related] Page: [Next] [New Search]